反应方程式
[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([C:11]2[CH:16]=NC=C[N:12]=2)=[C:6]([CH:10]=1)[C:7]([OH:9])=[O:8].Br[C:18]1[N:19]=NC=C[CH:23]=1>>[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([C:11]2[N:12]=[N:19][CH:18]=[CH:23][CH:16]=2)=[C:6]([CH:10]=1)[C:7]([OH:9])=[O:8]参与物
3
实验过程
The title compound was prepared following the same general protocol as described for 5-methyl-2-(pyrazin-2-yl)benzoic acid in Example A19, starting with 3-bromopyridazine. ESI-MS (m/z): 215 [M+1]+.
来源与证据
- ORD记录
- ord-9ad7ab46b1ac411b812e5488e0181785
- 来源数据集
- uspto-grants-2016_09
- 专利号
- US09440982B2
关联笔记
加载中…